Ambarella Rose on an NXP Takeover Report as CEVA Raised Guidance and Fell a Fifth
Hypothesis Opus 5 · Research Opus 5 · Writing Opus 5 · Prompt v1.4
Two small American chip companies sell the same idea — putting artificial-intelligence inference inside the camera, the car or the robot rather than in a data center — and over the past month their shares went opposite ways for reasons that have almost nothing to do with what they sold.
Ambarella, which designs vision chips, gained 19% in thirty days. Sixteen points of that came in one session, after the Financial Times reported NXP Semiconductors was in talks to buy it for more than $3bn. Its own revenue growth has slowed for four straight quarters, from 49.9% to 16.9%, and it has not reported since May.
CEVA, which licenses chip designs and collects royalties, fell 20.7% in the same window — into accelerating growth, a raised full-year guide and its best licensing quarter in three years. The one real crack: royalty dollars grew 1% while royalty units grew 16%.
| Ticker | Company | Segment | Trend · 13mo | 30D | 1Y |
|---|---|---|---|---|---|
| The subject · what this brief is about | |||||
AMBA | Ambarella | Specialty Semiconductors | 🟢 Cont. Bull | +32.7% | +19.0% |
CEVA | CEVA | Specialty Semiconductors | 🌱 Emerging Bull | −12.4% | +40.4% |
| Compared against · context, not the story | |||||
INDI | indie Semiconductor | RF & Wireless | 🌱 Emerging Bull | +23.0% | +7.5% |
NXPI | NXP Semiconductors | Analog & Mixed-Signal | 🟢 Cont. Bull | −11.9% | +2.6% |
AVGO | Broadcom | Semiconductor Subsystems | 🟢 Cont. Bull | +6.0% | +29.3% |
NVDA | NVIDIA | AI & Data Center GPUs | 🟢 Cont. Bull | +11.0% | +23.7% |
AMD | Advanced Micro Devices | AI & Data Center GPUs | 🟢 Cont. Bull | +3.8% | +192.0% |
MRVL | Marvell Technology | Specialty Semiconductors | 🟢 Cont. Bull | +17.7% | +189.9% |
MU | Micron Technology | Memory (DRAM/NAND) | 🟢 Cont. Bull | +14.5% | +687.6% |
STM | STMicroelectronics | Analog & Mixed-Signal | 🟢 Cont. Bull | −12.5% | +111.1% |
ALAB | Astera Labs | Specialty Semiconductors | 🟢 Cont. Bull | +5.9% | +72.5% |
ARM | Arm Holdings plc American Depositary Shares | Specialty Semiconductors | 🟢 Cont. Bull | +4.6% | +98.1% |
SPY | State Street SPDR S&P 500 ETF Trust | Asset Management | 🟢 Cont. Bull | +4.4% | +21.7% |
12-month price & trend
| Ticker | Mkt cap | P/E | P/E fwd | P/S | P/S fwd | P/GP | P/GP fwd | EV/EBITDA | FCF yld |
|---|---|---|---|---|---|---|---|---|---|
AMBA | $3.6B | n/m | 103.8x | 8.9x | 8.2x | 15.2x | 14.0x | n/m | 0.7% |
CEVA | $927.2M | n/m | 62.7x | 8.0x | 7.6x | 9.2x | 8.6x | n/m | -0.1% |
INDI | $995.2M | n/m | — | 4.3x | 3.7x | 20.0x | 17.4x | n/m | -8.4% |
| Ticker | Mkt cap | P/E | P/E fwd | P/S | P/S fwd | P/GP | P/GP fwd | EV/EBITDA | FCF yld |
|---|---|---|---|---|---|---|---|---|---|
NXPI | $58.5B | 19.7x | 15.4x | 4.4x | 4.1x | 7.9x | 7.3x | 13.5x | 5.1% |
AVGO | $1.9T | 63.5x | 33.9x | 24.8x | 17.7x | 37.0x | 26.4x | 45.6x | 1.8% |
NVDA | $5.5T | 34.3x | 25.0x | 21.5x | 13.9x | 29.0x | 18.7x | 28.3x | 2.2% |
| Ticker | Mkt cap | P/E | P/E fwd | P/S | P/S fwd | P/GP | P/GP fwd | EV/EBITDA | FCF yld |
|---|---|---|---|---|---|---|---|---|---|
AMD | $838.8B | 130.6x | 67.7x | 20.3x | 16.4x | 38.2x | 30.9x | 78.2x | 1.0% |
MRVL | $230.5B | 92.0x | 65.3x | 26.4x | 20.1x | 52.2x | 39.7x | 50.5x | 0.7% |
MU | $1.0T | 19.9x | 12.2x | 11.2x | 7.8x | 15.4x | 10.7x | 14.5x | 2.6% |
| Ticker | Mkt cap | P/E | P/E fwd | P/S | P/S fwd | P/GP | P/GP fwd | EV/EBITDA | FCF yld |
|---|---|---|---|---|---|---|---|---|---|
STM | $48.1B | 103.8x | 40.3x | 3.6x | 3.3x | 10.5x | 9.8x | 21.8x | 0.9% |
ALAB | $54.6B | 146.7x | 103.8x | 45.4x | 34.9x | 60.4x | 46.5x | 163.1x | 0.5% |
ARM | $222.5B | 245.9x | 96.2x | 45.2x | 37.2x | 47.8x | 39.3x | 161.3x | 0.4% |
| Ticker | Mkt cap | P/E | P/E fwd | P/S | P/S fwd | P/GP | P/GP fwd | EV/EBITDA | FCF yld |
|---|---|---|---|---|---|---|---|---|---|
SPY | $773.0B | — | — | — | — | — | — | — | — |
Consensus projections
| Ticker | FY2026E | FY2027E | FY2028E | |
|---|---|---|---|---|
AMBA | Revenue | +39.8% | +13.2% | +12.9% |
| EPS | −310.8% | +32.6% | +36.5% | |
CEVA | Revenue | +12.3% | +13.7% | +11.8% |
| EPS | +27.5% | +54.9% | +23.5% | |
INDI | Revenue | +22.8% | +35.4% | +44.7% |
| EPS | −44.1% | −131.9% | +471.0% | |
NXPI | Revenue | +16.6% | +11.5% | +8.2% |
| EPS | +28.0% | +20.6% | +15.7% | |
AVGO | Revenue | +66.6% | +65.5% | +33.9% |
| EPS | +71.7% | +68.7% | +33.7% | |
NVDA | Revenue | +65.1% | +84.2% | +43.2% |
| EPS | +59.0% | +91.7% | +42.0% | |
AMD | Revenue | +49.6% | +68.8% | +37.0% |
| EPS | +91.9% | +98.7% | +42.7% | |
MRVL | Revenue | +42.4% | +40.1% | +44.0% |
| EPS | +82.6% | +41.9% | +51.9% | |
MU | Revenue | +248.0% | +92.8% | +11.4% |
| EPS | +804.9% | +111.2% | +7.9% | |
STM | Revenue | +22.4% | +18.7% | +13.2% |
| EPS | +104.2% | +98.3% | +45.6% | |
ALAB | Revenue | +87.9% | +48.1% | +28.7% |
| EPS | +72.4% | +57.8% | +30.2% | |
ARM | Revenue | +22.5% | +22.0% | +32.6% |
| EPS | +7.9% | +24.1% | +38.8% |
Forward fiscal years only. Blank means no analyst coverage for that year.
On 31 July, the Financial Times reported that NXP Semiconductors was in talks to acquire Ambarella in a deal worth more than $3bn. Ambarella shares rose 16.1% that day on 9.2m shares, against typical volume of one to two million. Strip out that one session and the stock's entire last month amounts to about 2.6%.
Ambarella designs low-power system-on-chip silicon that squeezes video compression, image processing and computer vision onto a single part, sold to the makers of dashcams, security cameras, driver-assistance modules and robots. It is, on the user's own reading of the field, effectively the only Western listed pure-play left: Mobileye is roughly 88% owned by Intel, Hailo is private, and the Chinese alternatives are largely closed to Western original-equipment makers on export-control grounds. That scarcity is the takeover logic. Automotive is expected to supply about half of NXP's projected $15.1bn of 2026 revenue, and the deal would arrive in a consolidating industry that has already seen Texas Instruments buy Silicon Labs for $7.5bn this year.
The business behind the bid
What the report did not change is the trajectory. Ambarella's year-on-year revenue growth has decelerated for four consecutive quarters — 49.9%, then 31.2%, then 20.1%, then 16.9% in the quarter ended 30 April, on revenue of $100.4m. Gross margin has held up through it, at 59.1% in that quarter against 57.6% a year before, and the GAAP operating margin improved to -18.1% from -30.1%. The company is still loss-making. Consensus has full-year revenue growth of 13.2%, to $441m.
The shares carry 15.2x trailing gross profit, up from roughly 13.1x six months ago, and 104x forward earnings. Analysts pointed out that near $90 the company was worth about $4.0bn, or 9.6x trailing revenue — more than twice NXP's own sales multiple, and that a customary 25% premium to the pre-report close of $74.09 works out to $92.61, barely above where the stock traded on the news. Talks could still collapse. Ambarella has not reported since 28 May; it guided the current quarter to $105m-$111m.
The licensor that beat and fell
CEVA sells no chips. It licenses digital signal processor cores, its NeuPro neural-network accelerators and wireless connectivity designs to chipmakers, taking an upfront fee and then a royalty on every unit its customers ship. Four hundred employees produce an 87.4% gross margin — which is why the near-identical price-to-sales ratios of the two companies, 8.0x and 8.9x, mislead, and why gross profit is the fairer yardstick.
CEVA's growth has accelerated for four straight quarters, from 4.3% to 13.1%, and on 10 August it reported quarterly revenue of $29.0m with licensing up 21% to $18.2m — its strongest licensing quarter in three years. Non-GAAP operating margin reached 11%, from 3%. Management raised full-year growth guidance to 13-15% from 12%. The shares fell about 10% anyway, and are down 31.3% from their 15 June high.
There is one genuine problem in those numbers. Customers shipped 567m royalty-bearing units, up 16%, yet royalty dollars grew 1%, to $10.8m. Bluetooth volumes fell 16%, to 295m units, and low-priced consumer connectivity carried the mix — so the average royalty per unit is eroding even as units climb. Management's answer is to sell whole subsystems rather than components: ten licensing agreements last quarter, including one with what it described as a leading global AI and computing platform company that picked its NeuPro-M accelerator for custom silicon, with 18 to 24 months to production.
On price-to-gross-profit, CEVA has cheapened to 9.2x trailing from roughly 10.8x three months ago, as trailing gross profit rose 3.3% and the stock fell 12.4%. Ambarella trades at a 66% premium on the same measure. CEVA holds $221m of cash against a $927m market value.
The third name
Much of CEVA's drop was not about CEVA. In the last week of July, chip stocks lost more than $1 trillion of market value on reports that SK Hynix was slowing memory capacity expansion; CEVA fell 20.9% in that window and Ambarella, cushioned by its own story, was flat.
indie Semiconductor, which designs automotive chips for driver assistance, in-cabin systems and connectivity, is the third edge name often grouped with them. It grew revenue 24% to $64.0m last quarter, guided the current one to roughly 30% growth, and reported gross margin down to 36.1% from 40.6% with a $37.1m net loss. Its 18.8% jump on 14 August came with no discoverable company-specific news that day — CEVA rose 8.6% alongside it while Ambarella was unchanged and Broadcom fell 6.8%. It looks like a squeeze in small edge-AI names, and indie's own vision chip competes with Ambarella rather than validating either.
The setup
Where it stands — Ambarella's month is a takeover report; CEVA's is a sector selloff layered on royalty-mix erosion. Would confirm — CEVA's royalty dollars growing in line with unit shipments in the September quarter. Would invalidate — Ambarella reporting revenue above its $105m-$111m guide with growth reaccelerating past 20%. Watch next — Ambarella's fiscal second-quarter results, due late August; CEVA guided the September quarter to $30.5m-$34.5m. Valuation — Ambarella 15.2x trailing and 14.0x forward gross profit, versus CEVA's 9.2x and 8.6x.


















































































































